We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
RESEARCH SUPPORT, NON-U.S. GOV'T
Specific phobia in older adults: evidence from the national epidemiologic survey on alcohol and related conditions.
OBJECTIVE: This study aims to investigate: 1) the association of specific phobia with childhood parental loss and recent stressful life events; 2) the coexistence of specific phobia and major depressive disorders (MDDs); and 3) the impact of specific phobia on medical conditions, obesity, health service utilization, and health-related quality of life.
DESIGN: Cross-sectional observational study.
SETTING: The National Epidemiologic Survey on Alcohol and Related Conditions (2001-2002), a national representative survey of the noninstitutionized U.S. household population.
PARTICIPANTS: The 8,205 respondents aged 65 and above.
MEASUREMENTS: Specific phobia was assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition version. Demographic characteristics, psychosocial risk factors, psychiatric disorders, health-related quality of life, obesity, medical conditions, and health service utilization were measured.
RESULTS: The current and lifetime prevalence of specific phobia were 4.51% and 6.05%, respectively. Multivariate analyses revealed that specific phobia was more common among younger age groups, women, and those who reported stressful life events but less common among foreign-born individuals. In addition, MDD was significantly related to lifetime specific phobia. Specific phobia was also significantly related to a lower health-related quality of life and two medical conditions.
CONCLUSION: Our prevalence rates of specific phobia in the elderly are at the lower end of the ranges identified in the previous studies. The correlation between specific phobia and MDD raises further questions about the nature of specific phobia in the elderly. This study supports the notion that specific phobia has a strong impact on the quality of life in old age.
DESIGN: Cross-sectional observational study.
SETTING: The National Epidemiologic Survey on Alcohol and Related Conditions (2001-2002), a national representative survey of the noninstitutionized U.S. household population.
PARTICIPANTS: The 8,205 respondents aged 65 and above.
MEASUREMENTS: Specific phobia was assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition version. Demographic characteristics, psychosocial risk factors, psychiatric disorders, health-related quality of life, obesity, medical conditions, and health service utilization were measured.
RESULTS: The current and lifetime prevalence of specific phobia were 4.51% and 6.05%, respectively. Multivariate analyses revealed that specific phobia was more common among younger age groups, women, and those who reported stressful life events but less common among foreign-born individuals. In addition, MDD was significantly related to lifetime specific phobia. Specific phobia was also significantly related to a lower health-related quality of life and two medical conditions.
CONCLUSION: Our prevalence rates of specific phobia in the elderly are at the lower end of the ranges identified in the previous studies. The correlation between specific phobia and MDD raises further questions about the nature of specific phobia in the elderly. This study supports the notion that specific phobia has a strong impact on the quality of life in old age.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app